A comparative analysis of serological parameters and oxidative stress in osteoarthritis and Rheumatoid arthritis

Rheumatology International

Volumn 32, Issue 8, 2012, Pages 2377-2382

  Mishra, Rachana ^a   Singh, Aastha ^a   Chandra, Vishal ^a   Negi, Mahendra P S ^b   Tripathy, Baishnab C ^c   Prakash, Jaya ^d   Gupta, Varsha ^a  

^a CSJM UNIVERSITY   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

^c JAWAHARLAL NEHRU UNIVERSITY   (India)

^d Vinod Dixit Hospital   (India)

Author keywords

Cardiovascular disease; Cholesterol; Dyslipedemia; High density lipoprotein; Low density lipoprotein; Osteoarthritis; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; CREATININE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; GENDER; HUMAN; INFLAMMATION; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; OXIDATIVE STRESS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; TRIACYLGLYCEROL BLOOD LEVEL;

ANALYSIS OF VARIANCE; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHI-SQUARE DISTRIBUTION; CREATININE; FEMALE; HUMANS; INDIA; INFLAMMATION MEDIATORS; LIPIDS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OSTEOARTHRITIS; OXIDATIVE STRESS; URIC ACID;

EID: 84866235053     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-1964-1     Document Type: Article

References (42)

1. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M et al (1986) Development of criteria for the classification and reporting of osteoarthritis classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29:1039-1049
2. Arfaj AS (2003) Radiographic osteoarthritis and serum cholesterol. Saudi Med 24:745-747
3. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 31:315-324
4. Assous N, Touzé E, Meune C, Kahan A, Allanore Y (2007) Cardiovascular disease in rheumatoid arthritis: single-center hospital-based cohort study in France. Joint Bone Spine 74:66-72
5. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW (1988) Validation study of WOMAC a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833-1840
6. Bellamy N, Campbell J, Stevens J, Pilch L, Stewart C, Mahmood Z (1997) Validation study of a computerized version of the Western Ontario and McMaster Universities VA3.0 osteoarthritis index. J Rheumatol 24:2413-2415
7. Boers M, Nurmohamed MT, Doelman CJ, Lard LR, Verhoeven AC, Voskuyl AE, Huizinga TW, van de Stadt RJ, Dijkmans BA, van der Linden S (2003) Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis. Ann Rheum Dis 62:842-845
8. Bos SD, Suchiman HE, Kloppenburg M, Houwing-Duistermaat JJ, le Graverand MP, Seymour AB, Kroon HM, Slagboom PE, Meulenbelt I (2008) Allelic variation at the C-reactive protein gene associates to both hand osteoarthritis severity and serum high sensitive C-reactive protein levels in the GARP study. Ann Rheum Dis 67:877-879
9. Buchanan MJ, Isdale IC, Rose BS (1965) Serum uric acid estimation chemical and enzymatic methods compared. Ann Rheum Dis 24:285-288
10. Choi HK, Seeger JD (2005) Lipid profiles among US elderly with untreated rheumatoid arthritis-the Third National Health and Nutrition Examination Survey. J Rheumatol 32:2311-2316
11. Dahlqvist RS, Neumann-Andersen G, Backman C, Dahlen G, Stegmayr B (1997) Echocardiographic findings, lipids and lipoprotein(a) in patients with systemic lupus erythematosus. Clin Rheumatol 16:140-148
12. Dursunoǧlu D, Evrengül H, Polat B, Tanriverdi H, Cobankara V, Kaftan A, Kiliç M (2005) Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation. Rheumatol Int 25:241-245
13. Firestein GS (1997) Etiology and pathogenesis of rheumatoid arthritis. In: Kelley WN, Harris ED, Ruddy S, Sledge CB (eds) Textbook of rheumatology. Saunders, Philadelphia, pp 851-897
14. Georgiadis AN, Papavasiliou EC, Lourida ES, Alamanos Y, Kostara C, Tselepis AD, Drosos AA (2006) Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment - a prospective, controlled study. Arthritis Res Ther 8:R82
15. Grigolo B, Roseti L, Fiorini M, Facchini A (2003) Enhanced lipid peroxidation in synoviocytes from patients with osteoarthritis. J Rheumatol 30:345-347
16. Günther KP, Puhl W, Brenner H, Stürmer T (2002) Clinical epidemiology of hip and knee joint arthroses: an overview of the results of the "Ulm Osteoarthrosis Study". Z Rheumatol 61:244-249
17. Isomäki HA, Mutru O, Koota K (1975) Death rate and causes of death in patients with rheumatoid arthritis. Scand J Rheumatol 4:205-208
18. Karvounaris SA, Sidiropoulos PI, Papadakis JA, Spanakis EK, Bertsias GK, Kritikos HD, Ganotakis ES, Boumpas DT (2007) Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study. Ann Rheum Dis 66:28-33
19. Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494-502
20. Laurence LB (2001) In: Hardman JG, Limbird LE, Gilman AG (eds) Goodman and Gilmans: the pharmacological basis of therapeutics, 10th edn. McGraw-Hill Publishers, New York
21. Leheita O, Abed Elrazek NY, Younes S, Mahmoud AZ (2005) Lymphocytes subsets in osteoarthritis versus rheumatoid arthritis. Egypt J Immunol 12:113-124
22. Mutru O, Laakso M, Isomaki H, Koota K (1989) Cardiovascular mortality in patients with rheumatoid arthritis. Cardiology 76:71-77
23. Special communication (2001) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Executive summary of the third report of the National Cholesterol Education Program (NCEP). JAMA 285:2486-2497
24. Nurmohamed MT (2007) Atherogenic lipid profiles and its management in patients with rheumatoid arthritis. Vasc Health Risk Manag 3:845-852
25. Ohkawa H, Ohis N, Yagi K (1979) Assay of lipid peroxides in animal tissues by thiobarbituric reaction. Anal Biochem 95:351
26. Panoulas VF, Douglas KM, Milionis HJ, Stavropoulos-Kalinglou A, Nightingale P, Kita MD, Tselios AL, Metsios GS, Elisaf MS, Kitas GD (2007) Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology (Oxford) 46:1477-1482
27. Park YB, Choi HK, Kim MY, Lee WK, Song J, Kim DK, Lee SK (2002) Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study. Am J Med 113:188-193
28. Pawlowska J, Mikosik A, Soroczynska-Cybula M, Jóÿwik A, Łuczkiewicz A, Mazurkiewicz S, Lorczyñski A, Witkowski JM, Bryll E et al (2009) Different distribution of CD4 and CD8 T cells in synovial membrane and peripheral blood of rheumatoid arthritis and osteoarthritis patients. Folia Histochem Cyto Biologica 47:627-632
29. Prasad K, Lee P (2003) Suppression of oxidative stress as a mechanism of reduction of hypercholesterolemic atherosclerosis by aspirin. J Cardiovasc Pharmacol Ther 8:61-69
30. Sasaki JE, Krause MP, Gama MP, Hallage T, Buzzachera CF, Santos MG, Silva SG (2007) Influence of overall and abdominal adiposity on C-reactive protein levels in elderly women. Arq Bras Cardiol 89:231-236
31. Sattar N, McCarey DW, Capell H, McInnes IB (2003) Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 108:2957-2963
32. Solomon DH, Goodson NJ, Katz JN, Weinblatt ME, Avorn J, Setoguchi S, Canning C, Schneeweiss S (2006) Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis 65:1608-1612
33. Stavropoulos-Kalinoglou A, Metsios GS, Panoulas VF, Douglas KM, Nevill AM, Jamurtas AZ, Kita M, Koutedakis Y, Kitas GD (2009) Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis. Ann Rheum Dis 68:242-245
34. Steiner G, Urowitz MB (2009) Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment. Semin Arthritis Rheum 38:372-381
35. Sun Y, Brenner H, Sauerland S, Günther KP, Puhl W, Stürmer T (2000) Serum uric acid and patterns of radiographic osteoarthritis-the Ulm osteoarthritis study. Scand J Rheumatol 29:380-386
36. Tak PP, Bresnihan B (2000) The pathogenesis and prevention of joint damage in rheumatoid arthritis. Advances from synovial biopsy and tissue analysis. Arthritis Rheum 43:2619-2633
37. Turesson C, Jarenros A, Jacobsson L (2004) Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study. Ann Rheum Dis 63:952-955
38. Uchida K (2003) 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res 42:318-343
39. Vasiliades J (1976) Reaction of alkaline sodium picrate with creatinine: I. kinetics and mechanism of formation of the monocreatinine picric acid complex. Clin Chem 22:1664-1671
40. Wallberg-Jonsson S, Backman C, Johnson O, Karp K, Lundstrom E, Sundqvist KG, Rantapaa-Dahlqvist S (2001) Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis. J Rheumatol 28:2597-2602
41. Warrington KJ, Kent PD, Frye RL, Lymp JF, Kopecky SL, Goronzy JJ et al (2005) Rheumatoid arthritis in an independent risk factor for multi-vessel coronary artery disease: a case control study. Arthritis Res Ther 7:984-991
42. Watson DJ, Rhodes T, Guess HA (2003) All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK general practice research database. J Rheumatol 30:1196-1202